Dear Colleague Letters

At a glance

The Division of Tuberculosis (TB) Elimination publishes Dear Colleague Letters from the Division to partners about TB updates. Dear Colleague Letters are available from the past three years.

A person works on a laptop computer surrounded by email icons.

2024

Female doctor talking to male patient both wearing N95 masks

CDC Releases 2023 Provisional U.S. Tuberculosis Data

"Tuberculosis — United States, 2023" has information on provisional U.S. TB disease cases in 2023.

2023

Graphic illustration of Tuberculosis Trials Consortium (TBTC)

Tuberculosis Trials Consortium Launches New TB Clinical Trial

CDC's Tuberculosis Trials Consortium (TBTC) launched a new international clinical trial.
2022 Reported Tuberculosis in the United States

CDC Releases "Reported Tuberculosis in the United States, 2022"

CDC published "Reported Tuberculosis in the United States, 2022."
Uniting for Ukraine: Breathe Easier; Help people arriving from Ukraine get tested for tuberculosis.

CDC Releases New TB Resources for Uniting for Ukraine Arrivals

CDC announced new resources about the Uniting for Ukraine program TB screening requirements.
Health care provider reviews data at computer

Rapid Testing for Fluoroquinolone Resistance

Beginning May 24, 2023, CDC implemented rapid testing for fluoroquinolone (FQ) resistance.
A male pharmacist reviews information on a pharmacy computer

Tuberculosis Drug Supply Interruptions and Shortages

CDC encourages TB program to take proactive measures to reduce drug supply interruptions. 
Provisional Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease.

Updates to Provisional Guidance for the Use of Pretomanid as Part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease

CDC updated the 2022 Provisional Guidance for the BPaL Regimen to Treat Drug-resistant TB Disease.
World TB Day March 24

A Letter from Dr. Rochelle P. Walensky, CDC Director, on World Tuberculosis Day

Read a message for World TB Day 2023 from Dr. Rochelle P. Walensky, CDC Director.
World TB Day March 24

CDC U.S. World TB Day 2023 Resources

CDC's Division of TB Elimination shares information to assist in World TB Day 2023 planning efforts.

2022

Cover image of the 2020 Report of Verified Case of Tuberculosis (RVCT) Instruction Manual

Submission of 2023 TB Cases via 2020 RVCT

U.S. tuberculosis (TB) programs have until December 31, 2022 to implement the new TB reporting form.
2021 Reported Tuberculosis in the United States

CDC Releases “Reported Tuberculosis in the United States, 2021”

"Reported Tuberculosis in the United States, 2021" has information on U.S. TB disease cases. 
United States map with areas of coverage for the TB Centers of Excellence for Training, Education, and Medical Consultation (TB COE).

TB Centers of Excellence for Training, Education, and Medical Consultation Selection

Selected TB Centers of Excellence for Training, Education, and Medical Consultation (TB COE).
A health care provider performs a TB blood test.

Venezuelan Humanitarian Relief Program and TB Testing

Letter about health requirements for Venezuelans entering the United States under a new program.
Female health care worker smiling at a patient and holding a ruler to read a TB skin test on a patient's forearm

Timing of TST or IGRA in Relation to JYNNEOS Vaccine

CDC information on the timing of TST or IGRA in relation to the JYNNEOS vaccine.
An image of TB bacteria

Uniting for Ukraine – Drug Resistance Background and Recommendations

CDC provides information for TB programs if drug-resistant latent TB infection is presumed.

Uniting for Ukraine Program

This letter describes the TB screening requirements for the Uniting for Ukraine Program.
Graphic with a doctor and a statistic that reads "13M people in the U.S. have latent TB infection, and many don't know it."

A Letter from Dr. Rochelle P. Walensky, CDC Director, on World TB Day

Read a message for World TB Day 2022 from Dr. Rochelle P. Walensky, CDC Director.
Think. Test. Treat TB.

Think. Test. Treat TB: Campaign Announcement

CDC announces the Think. Test. Treat TB Campaign to raise awareness of latent TB infection.

CDC Releases Interim Guidance on a Four-Month TB Treatment Regimen

CDC released interim guidance on a four-month TB treatment regimen.
Provisional Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease

CDC Releases New Provisional Guidance for the Use of Pretomanid as Part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease

CDC has guidance on using bedaquiline, pretomanid, and linezolid to treat drug-resistant TB disease.
A health care provider watches a patient take TB medicine on a computer

In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence

A 2022 publication found that electronic DOT is noninferior to in-person DOT.
World TB Day March 24

CDC U.S. World TB Day 2022 Resources

Resources from CDC's Division of TB Elimination to assist in World TB Day 2022 planning efforts.
Under a high magnification of 15549x, this digitally-colorized, scanning electron microscopic (SEM) image depicted a number of Gram-positive, Mycobacterium tuberculosis bacteria.

Surveillance Definitions for Extensively Drug Resistant (XDR) and Pre-XDR Tuberculosis

This letter shares updated CDC definitions for extensively drug-resistant (XDR) and pre-XDR TB 
Print
Content Source:
Division of Tuberculosis Elimination ; National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; Centers for Disease Control and Prevention